GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. Logo

GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş.

A travel agency offering online booking for transport, hotels, cultural tours, and cruises.

GZNMI | IS

Overview

Corporate Details

ISIN(s):
TREGZNM00019 (+1 more)
LEI:
789000AQ1MOIA4NL0454
Country:
Türkiye
Address:
MEHMETÇİK MAH. 1242 SK. NO:3B / 2 MURATPAŞA, 07300 ANTALYA
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Gezinomi Seyahat Turizm Ticaret A.Ş. is a tour operator and travel agency established in 2011. The company's core business involves providing comprehensive travel arrangement and reservation services. Its offerings include ticket sales for air, sea, land, and rail transportation, as well as domestic and international hotel accommodations, cultural tours, and cruise packages. Operating through its website and mobile application, Gezinomi provides a digital platform for customers to plan and book their holidays. The company completed a successful Initial Public Offering in March 2022.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 17:16
Quarterly Report
Sorumluluk Beyanı - 30.09.2025
Turkish 25.7 KB
2025-11-10 17:16
Management Discussion and Analysis
Ara Dönem Faaliyet Raporu- 30.09.2025
Turkish 905.0 KB
2025-11-10 17:16
Report Publication Announcement
Ara Dönem Faaliyet Raporu- 30.09.2025
Turkish 11.0 KB
2025-11-10 17:15
Quarterly Report
Financial Report
Turkish 1.4 MB
2025-11-10 17:15
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-11-10 06:39
Legal Proceedings Report
Haber ve Söylentilere İlişkin Açıklama Hk.
Turkish 19.1 KB
2025-11-07 19:22
Registration Form
Bedelsiz Sermaye Artırımı ve Esas Sözleşme Tadili'ne İlişkin SPK Başvurusu Hakk…
Turkish 122.1 KB
2025-11-07 19:22
Share Issue/Capital Change
Bedelsiz Sermaye Artırımı ve Esas Sözleşme Tadili'ne İlişkin SPK Başvurusu Hakk…
English 15.8 KB
2025-11-06 16:10
Capital/Financing Update
Finansman Bonosu İhracına İlişkin Nitelikli Yatırımcıya Satışın Tamamlanması
English 22.3 KB
2025-11-05 07:21
Capital/Financing Update
Borçlanma Aracı İhracı Talep Toplama Hk.
English 21.9 KB
2025-11-05 07:03
Registration Form
Bedelsiz sermaye artırımına ilişkin yönetim kurulu kararı
Turkish 122.1 KB
2025-11-05 07:03
Share Issue/Capital Change
Bedelsiz sermaye artırımına ilişkin yönetim kurulu kararı
Turkish 16.9 KB
2025-10-14 14:43
Regulatory News Service
Borçlanma Aracı İhracına İlişkin İhraç Belgesi
Turkish 4.8 MB
2025-10-14 14:43
Capital/Financing Update
Borçlanma Aracı İhracına İlişkin İhraç Belgesi
Turkish 15.0 KB
2025-10-13 15:34
Regulatory News Service
Borçlanma Aracı İhracı SPK Onayı hakkında
Turkish 4.8 MB

Automate Your Workflow. Get a real-time feed of all GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GEZİNOMİ SEYAHAT TURİZM TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.